Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ACTRN12626000288325) titled 'A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Smartech Topical Aspirin Gel Formulation Following Multiple Applications in Healthy Adult Volunteers Compared to Oral Aspirin' on March 5.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Primary Sponsor: Smartech Topical AU Pty Ltd
Condition:
Cardiovascular
Cardiovascular
Cardiovascular - Other cardiovascular diseases
Intervention:
The purpose of this Phase 1 study is to evaluate the safety, tolerability and PK profile of ...